Matched study population | |||
---|---|---|---|
Parameter | LS + n = 82 | LS - n = 164 | p-value |
Medical circulatory support | |||
• Epinephrine required; n (%) | 68 (83) | 112 (68) | <0.001 |
• Duration Epinephrine [h]; median (IQR) | 19 (4.5–65) | 10 (0–38) | 0.01 |
• Nordrenaline required; n (%) | 79 (96) | 149 (91) | 0.058 |
• Duration Nordrenaline [h]; median (IQR) | 35 (15–68) | 20 (11–47) | 0.005 |
• Dobutamine required; n (%) | 41 (50) | 85 (52) | 0.68 |
• Duration Dobutamine [h]; median (IQR) | 25 (9–64) | 12 (8–36) | 0.83 |
• Milrinone required; n (%) | 10 (12) | 23 (14) | 0.73 |
• Duration Milrinone [h]; median (IQR) | 0.5 (0–14) | 2.3 (0–18) | 0.328 |
Mechanical circulatory support | |||
IABP insertion; n (%) | |||
• Intraoperatively | 9 (11) | 8 (4.9) | 0.072 |
• Postoperatively | 8 (9.8) | 2 (1.2) | 0.003 |
Duration IABP support [h]; median (IQR) | 51 (40–73) | 57 (26–75) | 0.30 |
ECLS implantation; n (%) | 6 (7.3) | 6 (3.7) | 0.40 |
Renal function | |||
Postoperative GFR [ml/min.]; mean (95%-CI) | 68 (50–86) | 70 (60–81) | 0.48 |
Postoperative GFR/preoperative GFR [ml/min.]; mean (95%-CI) | 1.0 (0.9–1.1) | 1.0 (0.9–1.1) | 0.47 |
Acute kidney injury; n (%) | |||
• AKIN I | 14 (17) | 37 (23) | 0.22 |
• AKIN II | 0 | 6 (3.7) | |
• AKIN III | 6 (7.3) | 6 (3.7) | |
New onset chronic dialysis; n (%) | 1 (1.2) | 3 (1.8) | 1.00 |
Cardiac Injury | |||
AF within 24h post-OP; n (%) | 62 (76) | 72 (44) | <0.0001 |
CK until POD4 [U/l]; mean (95%-CI) | 712 (368–1056) | 619 (400–839) | 0.402 |
CKMB until POD4 [U/l]; mean (95%-CI) | 47 (23–72) | 41 (29–54) | 0.17 |
Length of stay | |||
Postoperative LOS ICU [h]; median (IQR) | 150 (71–200) | 139 (67–168) | 0.047 |
Postoperative LOS total [d]; median (IQR) | 10 (8.0–13) | 11 (7.0–14) | 0.94 |